Details for New Drug Application (NDA): 020387
✉ Email this page to a colleague
The generic ingredient in HYZAAR is hydrochlorothiazide; losartan potassium. There are thirty-two drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; losartan potassium profile page.
Summary for 020387
| Tradename: | HYZAAR |
| Applicant: | Organon |
| Ingredient: | hydrochlorothiazide; losartan potassium |
| Patents: | 0 |
Pharmacology for NDA: 020387
| Mechanism of Action | Angiotensin 2 Receptor Antagonists |
| Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 020387
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HYZAAR | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 020387 | NDA | Organon LLC | 78206-139 | 78206-139-01 | 30 TABLET, FILM COATED in 1 BOTTLE (78206-139-01) |
| HYZAAR | hydrochlorothiazide; losartan potassium | TABLET;ORAL | 020387 | NDA | Organon LLC | 78206-139 | 78206-139-02 | 90 TABLET, FILM COATED in 1 BOTTLE (78206-139-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;50MG | ||||
| Approval Date: | Apr 28, 1995 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;100MG | ||||
| Approval Date: | Nov 10, 1998 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;100MG | ||||
| Approval Date: | Oct 20, 2005 | TE: | AB | RLD: | Yes | ||||
Expired US Patents for NDA 020387
Complete Access Available with Subscription
